Full-length spatial transcriptome strategy based on robust and low-cost target tissue capture
Biosensors and Bioelectronics · 2026
DOI: 10.1016/j.bios.2025.118018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2026. Verfasst von Ying Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Digital Medical Engineering, School of Biological Science & Medical Engineering, Southeast University, Nanjing, 210096, China. Hauptthemen laut MEDLINE: Parkinson Disease, Gene Expression Profiling, Biosensing Techniques, Transcriptome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: National Key Research and Development Program of China, China Postdoctoral Science Foundation, Postdoctoral Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Smart-seq2, a widely used method for constructing full-length mRNA transcriptome libraries, can be combined with target tissue capture techniques such as Laser Capture Microdissection (LCM) to achieve robust spatial transcriptomic profiling. However, both Smart-seq2 and LCM are limited by high costs and complex operation, hindering their broader adoption. Here, we report a full-length spatial transcriptome strategy based on a robust and cost-effective tissue capture technique, termed MSN-seq. MSN-seq integrates microneedle-based sampling with a modified Smart-seq2 protocol. This method captures multi-cellular tissue spots and not only optimises Smart-seq2 for enhanced performance but also leverages reusable steel needles to further reduce costs and improve transcriptomic capture efficiency. In addition to simplifying experimental procedures, MSN-seq increases accessibility by enabling spatial transcriptomic analysis without requiring specialised skills or expensive instrumentation. We applied MSN-seq to brain and retinal tissues from models of Parkinson's disease and retinal degeneration, demonstrating its effectiveness in capturing spatial transcriptomic data. Furthermore, application of MSN-seq to frozen sections from U251 glioblastoma model mice revealed early invasive mechanisms and spatially restricted enrichment of immune cell subsets. Overall, MSN-seq provides a low-cost, easy-to-use, and highly efficient strategy for acquiring spatial transcriptome data.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Digital Medical Engineering, School of Biological Science & Medical Engineering, Southeast University, Nanjing, 210096, China.
- State Key Laboratory of Digital Medical Engineering, School of Biological Science & Medical Engineering, Southeast University, Nanjing, 210096, China. Electronic address: geqinyu@seu.edu.cn.
- School of Medicine, Southeast University, Nanjing, 210097, China.
- State Key Laboratory of Digital Medical Engineering, School of Biological Science & Medical Engineering, Southeast University, Nanjing, 210096, China. Electronic address: zhlu@seu.edu.cn.
Förderung
- National Key Research and Development Program of China
- China Postdoctoral Science Foundation
- Postdoctoral Science Foundation of Jiangsu Province
- Southeast University
- Shenzhen Science and Technology Innovation Program
Zitieren
APA
Zhou, Y., Ge, Q., Li, M., Qi, T., Li, Z., Sheng, Y., Pan, M., Liu, Q., Zhao, X., & Lu, Z. (2026). Full-length spatial transcriptome strategy based on robust and low-cost target tissue capture. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2025.118018
Vancouver
Zhou Y, Ge Q, Li M, Qi T, Li Z, Sheng Y, et al. Full-length spatial transcriptome strategy based on robust and low-cost target tissue capture. Biosensors and Bioelectronics. 2026. doi:10.1016/j.bios.2025.118018
BibTeX
@article{Zhou2026,
author = {Zhou, Ying and Ge, Qinyu and Li, Moxin and Qi, Ting and Li, Zhihui and Sheng, Yuqi and Pan, Min and Liu, Quanjun and Zhao, Xiangwei and Lu, Zuhong},
title = {Full-length spatial transcriptome strategy based on robust and low-cost target tissue capture},
journal = {Biosensors and Bioelectronics},
year = {2026},
doi = {10.1016/j.bios.2025.118018}
}
EUVIMED